The Peaks and Me
Release time:
2022-04-06
■ Group Office Xu Xia
In 2007 , I joined Jianfeng Group. Because my major was journalism and I have been engaged in journalism, I was assigned to work in the editorial department of Jianfeng Newspaper.
On the first day of reporting for duty, I was looking for the office of the editorial department of Peak News on the second floor of Peak Building. I met Ye Niannian on the stairs and enthusiastically led me into the office and brought me to Fang Yaqing, then editor-in-chief. The editor-in-chief of
Fang Yaqing wears a pair of thick glasses and a thin figure. He looks very knowledgeable at first sight. With such thick lenses, he should read a lot of books. She introduced Fu Yiwu to me, now the editor-in-chief of the "Spike News". He said hello to me shyly.
After a few pleasantries, I found my desk. Editor-in-chief Fang asked Ye Niannian to bring me some of the previous "Spike Newspaper" so that I could get familiar with the situation of the enterprise first. In my spare time at work, we also chatted. The atmosphere in the whole office was relatively harmonious, and I quickly integrated into the group.
After a period of familiarity, 12 At the end of August, the company organized a reserve talent examination. This was the first time I received an interview. At the weekend, I went to the school of the examination early and secretly took some photos of the examinees in the examination. Seeing that Chairman Jiang Xiaomeng also came to inspect the examination room, I followed him to understand the situation and took photos. I felt that I was completing a major task and reminded myself to understand comprehensively and prepare more materials. A few days later, the reports and photos I wrote were published in the "Jianfeng Daily", and my name finally appeared on the page. At that time, I felt that my name could leave a mark on the long history of Jianfeng Group, but I was proud.
I have been in the editorial department for several years. In getting along with my colleagues, they have given me a lot of help and guidance. I have learned a lot, such as how to write an interview draft, how to write a speech, etc. There are many learning opportunities working in the editorial department. I remember one time when the correspondent organized an exchange and study in the "Garden News". At that time, the economic development level of Garden Village ranked among the national rankings. The corporate newspapers they run have advanced ideas and Ideas, development vision, excellent talents, and a lot of experience are worth learning. After some communication with them, I feel more gap. Communicating with other corporate newspapers has broadened my horizons and learned advanced ideas, which is still helpful to my work.
Now I have been away from the editorial department for more than 6 years. I still pay close attention to the "Peak Newspaper". Every time the newspaper is sent to my hand, I still habitually arrange them into a stack in chronological order, clip them with dovetail clips and put them on my desk for easy viewing. I have deep feelings for the "Peak News". After all, I have worked in the editorial department for 8 years, met many people, learned to deal with people, and improved my language skills. These are for my current job., Is also a great wealth.
"Peak News" was founded 30rd anniversary, she is like a woman in her prime, exuding a mature flavor, she is no longer as young as a young girl, after 30 years of experience, has its own goals, has its own personality, independent and beautiful. She guided me and nurtured me. My feelings with her cannot be described in words. She has always had a great weight in my heart.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31